BioNTech posts Q2 beat as revenue more than doubles

18 hours ago 1

• Earnings News
• Healthcare

Thomas Lohnes/Getty Images News

BioNTech (NASDAQ:BNTX) ADRs added ~2% in the premarket on Monday after the German vaccine maker exceeded Street forecasts with its Q2 2025 financials, thanks mainly to an over two-fold rise in its revenue.

The maker of the Pfizer (PFE

Recommended For You

More Trending News

See More »

1. Homepage
2. Politics
3. BioNTech posts Q2 beat as revenue more than doubles